Rare Disease Month spotlight: The top five psychological benefits of a genetic diagnosis
Every day we hear from families about what a difference a genetic diagnosis made in their lives. Here’s what they have to say.
Every day we hear from families about what a difference a genetic diagnosis made in their lives. Here’s what they have to say.
It may be more than you think. Understanding the fundamental cause of epilepsy can identify new treatments and ultimately reduce seizures.
University of Washington shared the latest research from the SeqFirst-Neo study at the 2024 annual meeting of the American Society of Human Genetics.
The latest research, presented today at ASHG, shows that GeneDx can confidently provide genomic answers for everyone, no matter their ancestry.
For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
This Epilepsy Awareness Month, we’re shining light on the genetic causes of seizures.
Findings from the first 4,000 newborns screened using GeneDx genome sequencing, were published today in the Journal of the American Medical Association (JAMA).
Ben’s illness started with seizures when he was just six months old.
His mother, Ashley, never stopped searching for answers—and finally found them with a genome test.
Inspired to share your story?
Leveraging our expansive genomic database, we’re working to transform care for pediatric patients. See GeneDx research being presented at the American Association of Human Genetics Annual Meeting.